Serum HE4 Detects Ovarian Cancer Recurrence Earlier Than CA 125: Indian Study
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 5
Abstract
ABSTRACT Introduction: Recurrence is a frequent phenomenon of the natural history of epithelial Ovarian Cancer (OC). Early detection of recurrence is important. Clinical examination combined with Carbohydrate Antigen 125 (CA125) and imaging are used for the follow-up of these patients. Human Epididymis Protein 4 (HE4) is a recent marker which is found to have elevated in OC. Aim: To study the role of HE4 in detection of OC recurrence. Materials and Methods: This prospective study was conducted at Department of Surgical Oncology, King George’s Medical University, Lucknow, Uttar Pradesh, India. Patients were enrolled from January 2014 to January 2016 after informed written consent. Total 65 patients of carcinoma ovary were prospectively followed up after completion of their primary treatment. 19 patients had clinical evidence of recurrence as detected by radiological imaging and subsequently proved by pathological examination. Timing and levels of rise in tumour marker were studied and correlated with timing of clinical evidence of disease. Results: HE4 and CA125 detected recurrence in 19 (100%) and 14 (73.7%) patients respectively. Among these 5 (26.3%) recurrence were detected by HE4 alone. In 10 (52.6%) patients, simultaneous rise in both of these markers were noticed and in 4 (21.1%) patients HE4 started rising before CA125 with a lead time of 3.25 months. CA125 was found to be in normal range in all mucinous carcinoma and two out of 16 serous carcinoma. Conclusion: HE4 is a potential useful serum marker to detect OC recurrence timely and better as compared to traditional utilised CA125. Future studies based on recurrence detection by HE4 may provide evidence on its role on survival.
Authors and Affiliations
Naseem Akhtar, Shiv Rajan, Vijay Kumar, Sonali Sharma, Sumaira Qayoom, Sourabh Mukharjee, Wahid Ali, Arun Chaturvedi
Keywords
Related Articles
- EP ID EP524338
- DOI 10.7860/JCDR/2018/35482.11542
- Views 65
- Downloads 0
The Serological Evidence of Cytomegalovirus Infection as a Potent Aetiological Factor for Cleft Lip/Palate, Mental Retardation and Deafness
Introduction: Congenital Cytomegalovirus (CCMV) infection is estimated to occur in 0.5% to 2% of all deliveries across the world. According to the available literature about Human Cytomegalovirus (HCMV) infected children...
Unilateral Paravertebral Block: An Alternative to Conventional Spinal Anaesthesia for Unilateral Uncomplicated Inguinal Hernia Repair
ABSTRACT Introduction: Inguinal hernia repair can be performed under general anaesthesia or various regional anaesthesia techniques like spinal, epidural or nerve blocks like hernia block or Paravertebral Block (PVB). Th...
Combined Thrombophilia in a Young Male Presenting as Life Threatening Pulmonary Embolism
Combined hereditary thrombophilia is an uncommon entity associated with higher risk of early onset thrombosis. We report a case of 39-year-old male with combined deficiency of natural anticoagulants (protein C, S and ant...
Comparative Study of Nanocrystalline Silver Ion Dressings with Normal Saline Dressings in Diabetic Foot Ulcers
ABSTRACT Introduction: Diabetic foot is a broad spectrum term which includes infection, ulceration and foot gangrene. Proper assessment of wound along with an aggressive multidisciplinary approach can reduce the risk of...
Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial
ABSTRACT Introduction: This is the first study in Indian paediatric subjects to evaluate the novel Measles, Mumps and Rubella (MMR) vaccine developed by M/s Cadila Healthcare Limited, India, containing the Hoshino mumps...